# ClearPoint Neuro and Blackrock Microsystems announce joint development agreement

ClearPoint Neuro announced a multi-product joint development and option agreement with Blackrock Microsystems to develop products for neurosurgery markets, including microelectrode recording platforms and smart biopsy needles. Initial product launches are expected in 2023.

- Type: Partnership
- Announced: 2021-02-11
- Where: Irvine, California and Salt Lake City, Utah, United States
- Status: announced
- Products: microelectrode recording platforms, smart biopsy needles, implantable neural electrodes
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [ClearPoint Neuro](https://endata.com/companies/53203.md) (partner)
- [Blackrock Microsystems](https://endata.com/companies/53204.md) (partner)

## Sources

- [rss.globenewswire.com](https://rss.globenewswire.com/news-release/2021/02/11/2174542/25687/en/clearpoint-neuro-inc-announces-multi-product-joint-development-option-agreement-with-blackrock-microsystems.html), 2021-02-11: "We are thrilled to announce this partnership with Blackrock and enter several existing Neurosurgery markets, representing an estimated combined addressable market of over $100 million, with differentiated and innovative products."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.